Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma

Jee Eun Yang, Eunji Park, Hyo Jeong Lee, Hyo Jeong Kang, Kang Mo Kim, Eunsil Yu, Danbi Lee, Ju Hyun Shim, Young-Suk Lim, Han Chu Lee, Young-Hwa Chung, Yung Sang Lee

Clin Mol Hepatol. 2014;20(1):28-37. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.28

View: 7619 Download: 63 Web of Science: 2 Crossref: 2

3

Evaluation of Predictive Value of Okuda, TNM, CLIP and JIS Staging Systems for Hepatocellular Carcinoma Patients

Sung-Wook Lee, M.D., Sang-Young Han, M.D., Kyoung-Tae Kim, M.D., Yang-Hyun Baek, M.D., In Young Koh, M.D., Byoung-Hee Kim, M.D., Eun-Hee Park, M.D., Jin-Seok Jang, M.D., Myung-Hwan Roh, M.D, Jong Cheol Choi, M.D.

Clin Mol Hepatol. 2007;13(2):196-207. Published online January 1, 1970

View: 2673 Download: 22

Survival Analysis for Patients with Hepatocellular Carcinoma according to Stage, Liver Function and Treatment Modalities

Kyung Woo Park , Joong Won Park , Sang Hyung Cho , Young Il Kim , Seong Hoon Kim , Hong Suk Park , Woo Jin Lee , Sang Jae Park , Dae Young Kim , Eun Kyoung Hong , Chang

Clin Mol Hepatol. 2006;12(1):41-54. Published online January 1, 1970

View: 3054 Download: 21

1 |

Viewed By 5145	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5009	MAFLD: How is it different from NAFLD?
Viewed By 4915	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3643	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3583	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search